[HTML][HTML] Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic …
JW Jung, HS Park, CS Park, SH Cho… - The Korean journal of …, 2021 - ncbi.nlm.nih.gov
Methods This study was conducted as a multicenter, single-group, open trial to evaluate the
improvement in the quality of life with the additional administration of omalizumab for 24 …
improvement in the quality of life with the additional administration of omalizumab for 24 …
[PDF][PDF] Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab
D Ediger, F Esra - Tuberk Toraks, 2023 - researchgate.net
Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life
experience with omalizumab Introduction: Omalizumab, a humanized monoclonal anti-IgE …
experience with omalizumab Introduction: Omalizumab, a humanized monoclonal anti-IgE …
Futuras terapias biológicas en el asma
S Quirce, I Bobolea, J Domínguez-Ortega… - Archivos de …, 2014 - Elsevier
Un porcentaje elevado de pacientes con asma no está controlado, incluso a pesar de seguir
un tratamiento adecuado. Esto indica que son necesarios tratamientos alternativos que …
un tratamiento adecuado. Esto indica que son necesarios tratamientos alternativos que …
Current and future asthma treatments: phenotypical approach on the path to personalized medicine in asthma
ID Bobolea, C Melero… - … CHILDHOOD ASTHMA to …, 2016 - books.google.com
Despite widely available and effective treatments, achieving asthma control is still an unmet
need for many patients. One of the explanations resides perhaps in the heterogeneity of the …
need for many patients. One of the explanations resides perhaps in the heterogeneity of the …
Универсальная информационная структура как инструмент длительного динамического мониторинга в аллергологии
ЕА Вишнёва, ЛС Намазова-Баранова… - Педиатрическая …, 2014 - cyberleninka.ru
Статья посвящена проблеме организации длительного динамического наблюдения
популяции пациентов в условиях реальной клинической практики. Каждое медицинское …
популяции пациентов в условиях реальной клинической практики. Каждое медицинское …
Current and future asthma therapies.
Corticosteroids (CST) are the gold standard for asthma management and for several
decades have been considered the cornerstone for asthma control. With the recent advent of …
decades have been considered the cornerstone for asthma control. With the recent advent of …
Registries as useful tools in characterization of allergic manifestations
EJ Jares, HA Badellino, LF Ensina - Current Opinion in Allergy and …, 2016 - journals.lww.com
Registries as useful tools in characterization of allergic m... : Current Opinion in Allergy and
Clinical Immunology Registries as useful tools in characterization of allergic manifestations …
Clinical Immunology Registries as useful tools in characterization of allergic manifestations …
Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
Asthma is a heterogeneous disease on a clinical as well as a mechanistic level. A major
molecular mechanism of asthma is considered to be driven by type 2 T-helper cells (Th2) …
molecular mechanism of asthma is considered to be driven by type 2 T-helper cells (Th2) …
Comparison of allergic asthma patients treated with omalizumab and non-allergic patients treated with continuous oral corticosteroids: results of five year follow-up …
B Gemicioğlu, B Duman - Tuberkuloz ve Toraks, 2016 - europepmc.org
Comparison of allergic asthma patients treated with omalizumab and non-allergic patients
treated with continuous oral corticosteroids: results of five year follow-up therapies. - Abstract …
treated with continuous oral corticosteroids: results of five year follow-up therapies. - Abstract …
Defining severe asthma–an approach to find new therapies
AM Nanzer, A Menzies-Gow - European Clinical Respiratory …, 2014 - Taylor & Francis
Asthma is a chronic inflammatory disease that has reached epidemic proportions worldwide.
It is treatable in the majority of patients, but there is no cure. Moreover, a proportion of …
It is treatable in the majority of patients, but there is no cure. Moreover, a proportion of …